Lilan Xin
Wuhan, 430071, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Discovery of Effective Dual PROTAC Degraders with Synergistic Antitumor Activity for Overcoming Tamoxifen-Resistant Breast Cancer.
Journal: Journal of medicinal chemistry
Published: July 07, 2026
A novel ERα-targeted hydrophobic tag degrader, overcomes tamoxifen resistance via unfolded protein response-induced apoptosis and homologous recombination repair inhibition in breast cancer.
Journal: Bioorganic chemistry
Published: March 03, 2026
A Novel Dual-Targeting PROTAC Overcomes Endocrine Resistance by Engaging Orthosteric and Allosteric Sites of Estrogen Receptor α.
Journal: Journal of medicinal chemistry
Published: February 15, 2026
Hydrophobic Tag Degraders Overcome Endocrine-Resistant Breast Cancer by Recruiting HSP27-Mediated E3 Ligase Complex for ERα Proteasomal Degradation.
Journal: Angewandte Chemie (International ed. in English)
Published: November 21, 2025
A distinct zearalenone detoxification strategy mediated by cytochrome P450.
Journal: Food chemistry
Published: November 12, 2025
Hydrophobic tagging: A promising paradigm for targeted protein degradation.
Journal: Cell insight
Published: September 28, 2025
Discovery of ERα-targeting PROTACs with intrinsic fluorescence for precision theranostics of breast cancer.
Journal: RSC medicinal chemistry
Published: April 02, 2025
Pegylated NIR Fluorophore-Conjugated OBHSA Prodrug for ERα-Targeted Theranostics with Enhanced Imaging and Long-Term Retention.
Journal: Molecules (Basel, Switzerland)
Published: November 07, 2024
Mechano-oncogenic cytoskeletal remodeling drives leukemic transformation with mitochondrial vesicle-mediated STING activation.
Journal: Cell stem cell
Published: September 16, 2024
Corrigendum to "Structure-guided identification of novel dual-targeting estrogen receptor α degraders with aromatase inhibitory activity for the treatment of endocrine-resistant breast cancer" [Eur. J. Med. Chem. 253 (2023) 115328].
Journal: European journal of medicinal chemistry
Published: July 27, 2024
Discovery of Novel ERα and Aromatase Dual-Targeting PROTAC Degraders to Overcome Endocrine-Resistant Breast Cancer.
Journal: Journal of medicinal chemistry
Published: May 29, 2024
Novel Acyl Thiourea-Based Hydrophobic Tagging Degraders Exert Potent Anti-Influenza Activity through Two Distinct Endonuclease Polymerase Acidic-Targeted Degradation Pathways.
Journal: Journal of medicinal chemistry
Published: May 22, 2024
Last Updated: 09/26/2026